What happens when you stop taking metformin
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Effects of Stopping Metformin: A Comprehensive Overview
Introduction to Metformin and Its Use in Diabetes Management
Metformin is a widely prescribed medication for managing type 2 diabetes mellitus (T2DM). It is known for its efficacy in lowering blood glucose levels and improving metabolic parameters. However, discontinuation of metformin can lead to various physiological changes and potential health risks. This article synthesizes findings from multiple studies to understand the consequences of stopping metformin.
Impact on Glycemic Control and Body Weight
Glycemic Control Deterioration
One of the most immediate effects of stopping metformin is a significant deterioration in glycemic control. Studies have shown that patients who discontinue metformin experience substantial increases in hemoglobin A1c (HbA1c) levels, indicating poorer blood sugar management . This deterioration is particularly pronounced in individuals who had poor glycemic control before starting metformin.
Weight Gain
Discontinuation of metformin is also associated with weight gain. Research indicates that patients who stop taking metformin tend to see an increase in body mass index (BMI) and overall body weight . This weight gain can negate the beneficial effects metformin had on metabolic health, particularly in patients with schizophrenia treated with clozapine, where the weight reduction benefits of metformin were lost after stopping the medication.
Risk of Diabetes Development
Increased Diabetes Incidence
In the context of diabetes prevention, stopping metformin has been linked to an increased risk of developing diabetes. The Diabetes Prevention Program (DPP) found that while metformin significantly reduced the risk of diabetes, this protective effect was partially lost after discontinuation. The incidence of diabetes increased after a short washout period, although the overall risk remained lower compared to those who never took metformin.
Metabolic and Microvascular Complications
Metabolic Abnormalities
Metformin discontinuation can lead to the re-emergence of metabolic abnormalities. For instance, patients who stopped metformin showed elevated fasting plasma glucose levels and worsened lipid profiles. Additionally, the gut-based pharmacology of metformin, which includes alterations in bile acid recirculation and gut microbiota, reverses upon stopping the drug, leading to reduced levels of beneficial gut hormones like GLP-1.
Microvascular and Cardiovascular Events
Interestingly, some studies have found that stopping metformin does not significantly impact the incidence of microvascular diabetic complications, cardiovascular events, or overall mortality. Patients with conditions like coronary heart disease (CHD), congestive heart failure (CHF), and chronic obstructive pulmonary disease (COPD) did not show increased mortality or cardiovascular events after stopping metformin.
Practical Considerations for Discontinuation
Short-Term Discontinuation for Diagnostic Procedures
In some cases, short-term discontinuation of metformin is necessary for diagnostic procedures, such as PET/CT scans. Studies have shown that stopping metformin for a few days can significantly reduce high intestinal FDG uptake, which is beneficial for clearer imaging results without significantly affecting blood glucose levels .
Conclusion
Stopping metformin can lead to significant negative effects on glycemic control, body weight, and metabolic health. While some benefits of metformin, such as reduced diabetes risk, may persist to some extent, the overall impact of discontinuation is largely detrimental. Therefore, patients and healthcare providers should carefully consider the implications of stopping metformin and explore alternative strategies to maintain metabolic health.
Sources and full results
Most relevant research papers on this topic